NZ242367A - Carbamate derivatives of rapamycin and pharmaceutical compositions thereof - Google Patents

Carbamate derivatives of rapamycin and pharmaceutical compositions thereof

Info

Publication number
NZ242367A
NZ242367A NZ24236792A NZ24236792A NZ242367A NZ 242367 A NZ242367 A NZ 242367A NZ 24236792 A NZ24236792 A NZ 24236792A NZ 24236792 A NZ24236792 A NZ 24236792A NZ 242367 A NZ242367 A NZ 242367A
Authority
NZ
New Zealand
Prior art keywords
rapamycin
carbon atoms
ester
compound
group
Prior art date
Application number
NZ24236792A
Other languages
English (en)
Inventor
Wenling Kao
Robert Lewis Vogel
John Henry Musser
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/686,728 external-priority patent/US5118678A/en
Priority claimed from US07/837,048 external-priority patent/US5194447A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of NZ242367A publication Critical patent/NZ242367A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ24236792A 1991-04-17 1992-04-15 Carbamate derivatives of rapamycin and pharmaceutical compositions thereof NZ242367A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/686,728 US5118678A (en) 1991-04-17 1991-04-17 Carbamates of rapamycin
US07/837,048 US5194447A (en) 1992-02-18 1992-02-18 Sulfonylcarbamates of rapamycin

Publications (1)

Publication Number Publication Date
NZ242367A true NZ242367A (en) 1994-07-26

Family

ID=27103855

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ24236792A NZ242367A (en) 1991-04-17 1992-04-15 Carbamate derivatives of rapamycin and pharmaceutical compositions thereof

Country Status (12)

Country Link
EP (1) EP0509795A2 (cg-RX-API-DMAC10.html)
JP (1) JPH05112573A (cg-RX-API-DMAC10.html)
KR (1) KR920019798A (cg-RX-API-DMAC10.html)
AU (1) AU642592B2 (cg-RX-API-DMAC10.html)
CZ (1) CZ117392A3 (cg-RX-API-DMAC10.html)
FI (1) FI921595A7 (cg-RX-API-DMAC10.html)
HU (1) HU9201254D0 (cg-RX-API-DMAC10.html)
IE (1) IE921249A1 (cg-RX-API-DMAC10.html)
MX (1) MX9201710A (cg-RX-API-DMAC10.html)
NO (1) NO921449L (cg-RX-API-DMAC10.html)
NZ (1) NZ242367A (cg-RX-API-DMAC10.html)
SK (1) SK117392A3 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776943A (en) * 1991-05-14 1998-07-07 American Home Products Corporation Rapamycin metabolites
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
WO1993018043A1 (en) * 1992-03-05 1993-09-16 American Home Products Corporation Novel rapamycin 42-sulfonates and 42-(n-carboalkoxy)sulfamates useful as immunosuppressive agents
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2377847T3 (es) 1999-01-13 2012-04-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
DE60012192T2 (de) * 1999-08-18 2005-09-08 Wyeth Wasserlösliche sdz-rad ester
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
ES2288694T3 (es) 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation Diaril ureas para enfermedades mediadas por el receptor del factor de crecimiento derivado de plaquetas.
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
CA2544731A1 (en) * 2003-11-03 2005-05-12 Altachem Pharma Ltd. Rapamycin peptides conjugates: synthesis and uses thereof
US8021849B2 (en) 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
EP1856131A1 (en) 2005-03-07 2007-11-21 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
MX2021008930A (es) * 2019-01-25 2021-11-04 Nodthera Ltd Derivados de carbamato y sus usos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
PT98990A (pt) * 1990-09-19 1992-08-31 American Home Prod Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin

Also Published As

Publication number Publication date
IE921249A1 (en) 1992-10-21
AU642592B2 (en) 1993-10-21
FI921595A0 (fi) 1992-04-10
HU9201254D0 (en) 1992-07-28
CZ117392A3 (en) 1993-09-15
NO921449D0 (no) 1992-04-10
JPH05112573A (ja) 1993-05-07
EP0509795A2 (en) 1992-10-21
FI921595L (fi) 1992-10-18
KR920019798A (ko) 1992-11-20
SK117392A3 (en) 1995-04-12
AU1488092A (en) 1992-10-22
EP0509795A3 (cg-RX-API-DMAC10.html) 1994-03-23
MX9201710A (es) 1993-01-01
FI921595A7 (fi) 1992-10-18
NO921449L (no) 1992-10-19

Similar Documents

Publication Publication Date Title
US5194447A (en) Sulfonylcarbamates of rapamycin
US5118678A (en) Carbamates of rapamycin
NZ242367A (en) Carbamate derivatives of rapamycin and pharmaceutical compositions thereof
EP0730597B1 (en) Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
US5252579A (en) Macrocyclic immunomodulators
US5489595A (en) Carbamates of rapamycin
US5385910A (en) Gem-distributed esters of rapamycin
US5455249A (en) Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5411967A (en) Carbamates of rapamycin
EP0713490B1 (en) C-22 ring stabilized rapamycin derivatives
CA2108068C (en) Carbamates of rapamycin
US5530007A (en) Carbamates of rapamycin
US5508290A (en) Hindered N-oxide esters of rapamycin
US5262424A (en) Composition of sulfonylcarbamates of rapamycin and method of treating diseases requiring immunosuppression therewith
MXPA97003893A (en) Un-oxido-impaired esters of rapamycin and its uses as a medicine
EP0593227B1 (en) Carbamates of rapamycin
AU5007193A (en) 27-hydroxyrapamycin and derivatives thereof
KR100304327B1 (ko) 라파마이신의카밤산염및이를포함하는약제학적조성물
HK1011357A (en) Carbamates of rapamycin
HK1011354B (en) Heterocyclic esters of rapamycin and pharmaceutical compositions containing them